Works matching DE "EPOXYEICOSATRIENOIC acids"


Results: 234
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0215033
    By:
    • Reisdorf, William C.;
    • Xie, Qing;
    • Zeng, Xin;
    • Xie, Wensheng;
    • Rajpal, Neetu;
    • Hoang, Bao;
    • Burgert, Mark E.;
    • Kumar, Vinod;
    • Hurle, Mark R.;
    • Rajpal, Deepak K.;
    • O’Donnell, Sarah;
    • MacDonald, Thomas T.;
    • Vossenkämper, Anna;
    • Wang, Lin;
    • Reilly, Mike;
    • Votta, Bart J.;
    • Sanchez, Yolanda;
    • Agarwal, Pankaj
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    Epoxyeicosanoids in Hypertension.

    Published in:
    Physiological Research, 2019, v. 68, n. 5, p. 695, doi. 10.33549/physiolres.934291
    By:
    • IMIG, J. D.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

    Published in:
    Nature, 2015, v. 523, n. 7561, p. 468, doi. 10.1038/nature14569
    By:
    • Li, Pulin;
    • Lahvic, Jamie L.;
    • Binder, Vera;
    • Pugach, Emily K.;
    • Riley, Elizabeth B.;
    • Tamplin, Owen J.;
    • Panigrahy, Dipak;
    • Bowman, Teresa V.;
    • Barrett, Francesca G.;
    • Heffner, Garrett C.;
    • McKinney-Freeman, Shannon;
    • Schlaeger, Thorsten M.;
    • Daley, George Q.;
    • Zeldin, Darryl C.;
    • Zon, Leonard I.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    Erratum.

    Published in:
    2014
    Publication type:
    Correction Notice
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50